Following the enforcement of the EU Falsified Medicines Directive and the US Drug Supply Chain Security Act, many companies have had to invest substantially to meet the serialization requirements.
Compliance to these regulations has come at a heavy price, both financially and operationally.
This has been especially true for companies operating a high-volume, low-margin business model or those facing pressure to reduce costs.
Post serialization deadline, the overriding focus has been on ensuring compliance for all relevant product lines.
However, now that many companies are fully underway with their compliance initiatives, attention is shifting to how the serialization infrastructure could be utilized to generate value.
Companies are starting to test out initiatives to optimize processes, improve decision making and increase responsiveness using their new systems and data.
In this report, we’ll discuss 5 areas where you can use serialized data to generate commercial value
We'll cover how you can:
- Gain oversight on supply chain operations
- Ensure accurate returns management
- Act quickly on pressing issues
- Track and action trends
- Facilitate supply chain collaboration
Download your copy of the report now!
Download PDF Attachment